![A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial | Leukemia A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-019-0539-0/MediaObjects/41375_2019_539_Fig3_HTML.png)
A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial | Leukemia
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age | Haematologica
![Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network | Leukemia Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-020-0918-6/MediaObjects/41375_2020_918_Fig1_HTML.png)
Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network | Leukemia
![Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma | JCO Clinical Cancer Informatics Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma | JCO Clinical Cancer Informatics](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/cci/2018/cci.2018.2/cci.18.00043/20180817/images/large/cci.18.00043t2.jpeg)
Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma | JCO Clinical Cancer Informatics
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients | PLOS
![Web-based software applications for frailty assessment in older adults: a scoping review of current status with insights into future development | BMC Geriatrics | Full Text Web-based software applications for frailty assessment in older adults: a scoping review of current status with insights into future development | BMC Geriatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12877-021-02660-6/MediaObjects/12877_2021_2660_Fig2_HTML.png)
Web-based software applications for frailty assessment in older adults: a scoping review of current status with insights into future development | BMC Geriatrics | Full Text
![Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma - Li - Cancer Medicine - Wiley Online Library Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma - Li - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6ce7153d-e179-42a3-b574-f96c77af54d5/cam45422-fig-0002-m.jpg)
Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma - Li - Cancer Medicine - Wiley Online Library
![Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review | Semantic Scholar Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a3c783d934bf8a632fd1d315bc2eaf9c02b382d1/2-Table1-1.png)
Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review | Semantic Scholar
![Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study - The Lancet Healthy Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study - The Lancet Healthy](https://www.thelancet.com/cms/attachment/16c90253-b7a5-4f4a-b007-03d25c502060/gr2_lrg.jpg)
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study - The Lancet Healthy
![Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older - ScienceDirect Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879406818303436-gr1.jpg)
Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older - ScienceDirect
![Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma | JCO Clinical Cancer Informatics Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma | JCO Clinical Cancer Informatics](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/cci/2018/cci.2018.2/cci.18.00043/20180817/images/large/cci.18.00043t3.jpeg)
Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma | JCO Clinical Cancer Informatics
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
![NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022 in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 1 (2022) NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022 in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 1 (2022)](https://jnccn.org/view/journals/jnccn/20/1/full-jnccn2001glisfx1.jpg)